FDA issued its first DSCSA Form 483 to a physician-owned practice in 2026
FDA issued its first DSCSA Form 483 to a physician-owned practice in 2026
For years, DSCSA enforcement focused upstream manufacturers and wholesalers.
That phase is complete.
FDA inspections are now evaluating medical practices that purchase, store, and administer Rx products in-office. And they’re asking for documented proof of sourcing, traceability, and reconciliation.
This isn’t theoretical. It’s operational.
The New York Department of State just completed a statewide sweep of MedSpa providers 87 violations, suspended licenses, and revoked credentials. If your practice administers Botox, fillers, or any injectable, here is what you need to know about your drug supply chain before someone shows up at your door.
Coming Soon
Copyright © 2026 claritasaxis.com - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.